Corebridge Financial Inc. Has $7.39 Million Stock Position in Bruker Co. (NASDAQ:BRKR)

Corebridge Financial Inc. lowered its position in Bruker Co. (NASDAQ:BRKR) by 4.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 126,007 shares of the medical research company’s stock after selling 5,488 shares during the quarter. Corebridge Financial Inc. owned 0.08% of Bruker worth $7,387,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the company. True Wealth Design LLC lifted its position in Bruker by 4,636.4% in the third quarter. True Wealth Design LLC now owns 521 shares of the medical research company’s stock worth $36,000 after purchasing an additional 510 shares during the period. Eagle Bay Advisors LLC lifted its holdings in shares of Bruker by 2,324.1% during the 4th quarter. Eagle Bay Advisors LLC now owns 703 shares of the medical research company’s stock worth $41,000 after acquiring an additional 674 shares during the period. UMB Bank n.a. boosted its position in shares of Bruker by 37.5% during the 4th quarter. UMB Bank n.a. now owns 909 shares of the medical research company’s stock valued at $53,000 after acquiring an additional 248 shares in the last quarter. GAMMA Investing LLC increased its stake in Bruker by 47.5% in the fourth quarter. GAMMA Investing LLC now owns 1,279 shares of the medical research company’s stock valued at $75,000 after acquiring an additional 412 shares during the period. Finally, EverSource Wealth Advisors LLC raised its position in Bruker by 41.5% in the fourth quarter. EverSource Wealth Advisors LLC now owns 1,330 shares of the medical research company’s stock worth $78,000 after purchasing an additional 390 shares in the last quarter. 79.52% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms have recently weighed in on BRKR. The Goldman Sachs Group upgraded Bruker from a “sell” rating to a “neutral” rating and set a $60.00 price objective on the stock in a research note on Thursday, December 5th. Barclays dropped their price objective on Bruker from $69.00 to $65.00 and set an “overweight” rating for the company in a research note on Monday, February 10th. UBS Group started coverage on shares of Bruker in a research note on Tuesday, December 10th. They issued a “neutral” rating and a $66.00 target price on the stock. Bank of America increased their target price on shares of Bruker from $78.00 to $80.00 and gave the stock a “buy” rating in a research report on Friday, December 13th. Finally, Stifel Nicolaus reduced their price target on shares of Bruker from $70.00 to $57.00 and set a “hold” rating on the stock in a research report on Friday, February 14th. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $70.50.

Bruker Price Performance

Shares of BRKR stock opened at $42.08 on Friday. The company has a current ratio of 1.60, a quick ratio of 0.77 and a debt-to-equity ratio of 1.15. The firm has a market capitalization of $6.38 billion, a price-to-earnings ratio of 55.37, a PEG ratio of 2.16 and a beta of 1.18. The firm’s 50 day moving average is $50.54 and its 200-day moving average is $57.01. Bruker Co. has a 1 year low of $41.80 and a 1 year high of $94.35.

Bruker (NASDAQ:BRKR) last announced its quarterly earnings data on Thursday, February 13th. The medical research company reported $0.76 EPS for the quarter, beating analysts’ consensus estimates of $0.75 by $0.01. Bruker had a return on equity of 21.01% and a net margin of 3.36%. Sell-side analysts forecast that Bruker Co. will post 2.69 EPS for the current fiscal year.

Bruker Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 28th. Shareholders of record on Monday, March 17th were issued a dividend of $0.05 per share. The ex-dividend date of this dividend was Monday, March 17th. This represents a $0.20 annualized dividend and a yield of 0.48%. Bruker’s dividend payout ratio is currently 26.32%.

Bruker Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.